Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last €51.26 EUR
Change Today -1.61 / -3.05%
Volume 1.5M
DSM On Other Exchanges
Symbol
Exchange
OTC US
EN Amsterdam
Frankfurt
As of 11:39 AM 04/17/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Hugh C. Welsh

President of DSM North America and General Counsel of DSM North America, Koninklijke DSM N.V.
AgeTotal Calculated CompensationThis person is connected to 100 board members in 2 different organizations across 3 different industries.

See Board Relationships
47--

Background*

Mr. Hugh C. Welsh has been the President of DSM North America at Royal DSM N.V. since October 1, 2010 and as its General Counsel. Mr. Welsh serves as Vice President of Group Legal Affairs of DSM Pharmaceutical Products, Inc. Before joining DSM, he worked for the American Standard Companies McCarter & English LLP and others. He serves as a Director of Kensey Nash Corporation. He served as a Director and Member of Industrial and Environmental Section Governing Board at ...

Read Full Background

Corporate Headquarters*

Het Overloon 1
Heerlen, Limburg 6411 TE

Netherlands

Phone: 31 45 578 8111
Fax: --

Board Members Memberships*

Director
Director

Education*

Bachelor's Degree 1990
University Of Massachusetts
JD 1993
Seton Hall University School Of Law

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
DSM:NA €51.26 EUR -1.61

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Mark J. Costa Chairman and Chief Executive Officer
Eastman Chemical Co.
$987.3K
Jean-Pierre Clamadieu Chief Executive Officer, Director and Member of Finance Committee
Solvay SA
€2.5M
Mark C. Rohr Chairman of the Board, Chief Executive Officer and President
Celanese Corporation
$1.1M
Robert J. MacLeod Chief Executive, Executive Director and Member of Chief Executive's Committee
Johnson Matthey plc
856.0K GBP
Daniel Servitje Montull Chairman, Chief Executive Officer, Member of Advisory Board, Member of Evaluation & Results Committee and Member of Finance & Planning Committee
Grupo Bimbo, S.A.B. de C.V.
--
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact KONINKLIJKE DSM NV, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.